Abstract Poster Wall
2022 Kidney Cancer Research Summit
Abstract 27
Evaluation of Growth Rates for Small Renal Masses in Elderly Patients Undergoing Active Surveillance
Ridwan Alam MD, MPH
Abstract 32
VHL-mediated ubiquitination of the kinase Mps1 regulates the mitotic checkpoint in clear cell renal cell carcinoma
Mark Woodford PhD
Abstract 34
Monitoring Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
Scott Haake MD, PhD
Abstract 36
Cytoreductive Nephrectomy with Concomitant IVC Tumor Thrombectomy in Metastatic Renal Cell Carcinoma
Pranjal Agrawal MD
Abstract 44
Outcomes of patients with advanced variant histology renal cell carcinoma (RCC) treated with systemic therapy
Danielle Urman
Abstract 48
Characterization of FH variants in their role in HLRCC-associated kidney cancer
Blake R Wilde PhD
Abstract 51
Investigating germline susceptibility to renal cell carcinoma within the Canadian population
Kate I Glennon BSc
Abstract 55
Biomarkers of Disease Burden and Treatment Response in Renal Medullary Carcinoma
Kyle Blum MD, MS
Abstract 58
The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect in renal cancer
Jennifer Heritz
Abstract 65
Correlation of serum iron level and duration of response to ipilimumab and nivolumab in metastatic clear cell renal carcinoma (mccRCC)
James Brundage MS
Abstract 67
Impact of Age on Functional Decline Following Radical Nephrectomy: Analysis of the International Marker Consortium for Renal Cancer (INMARC)
Mimi Nguyen BS
Abstract 71
Clinical and genomic characteristics of patients with metastatic renal cell carcinoma who developed venous thromboembolism
Nicolas Sayegh MD
Abstract 79
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressively advanced stages of renal cell carcinoma, including brain metastases
David Schoenfeld MD, PhD
Abstract 82
A Comparison of Radiographic and Morphometric Characteristics and Outcomes in T3A Pathologically Upstaged and Non-Upstaged Renal Cell Carcinoma
Saeed Ghassemzadeh
Abstract 85
Pulmonary and cutaneous manifestations of Birt-Hogg-Dube Syndrome in a large clinical cohort
Brian Cortese BS
Abstract 87
The Mutational Landscape of Resected Clear Cell Renal Cell Carcinoma with Cystic components
Laura Bukavina MD, MPH
Abstract 90
The role of exercise on the physical and mental health of kidney cancer patients and survivors
Khalid Alkhatib MD, MMSc
Posters: Trials in Progress
Abstract 39
Phase II Trial of Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma
Kevin Zarrabi MD, MS
Abstract 49
A Phase 1/2, Open Label Dose-Escalation and Expansion Trial of NKT2152, an orally administered HIF2α inhibitor, to investigate safety. PK, PD and clinical activity in patients with advanced ccRCC
Toni Choueiri MD